{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T05:29:05Z","timestamp":1772688545815,"version":"3.50.1"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,1,22]],"date-time":"2027-01-22T00:00:00Z","timestamp":1800576000000},"content-version":"am","delay-in-days":266,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["K01DA060986"],"award-info":[{"award-number":["K01DA060986"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015615","name":"National Institute on Drug Abuse Clinical Trials Network","doi-asserted-by":"publisher","award":["1UG1DA049444"],"award-info":[{"award-number":["1UG1DA049444"]}],"id":[{"id":"10.13039\/100015615","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011959","name":"Institute of Development and Economic Alternatives","doi-asserted-by":"publisher","award":["CIN 13-414"],"award-info":[{"award-number":["CIN 13-414"]}],"id":[{"id":"10.13039\/501100011959","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jsatjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Substance Use and Addiction Treatment"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.josat.2026.209902","type":"journal-article","created":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T16:59:05Z","timestamp":1769014745000},"page":"209902","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Treatment of opioid use disorder in pregnancy among individuals with and without co-occurring stimulant use disorder: A retrospective cohort study"],"prefix":"10.1016","volume":"184","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5171-1625","authenticated-orcid":false,"given":"Elizabeth","family":"Charron","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amanda A.","family":"Allshouse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Casey","family":"Tak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristine A.","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2453-8871","authenticated-orcid":false,"given":"Adam J.","family":"Gordon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerald","family":"Cochran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcela C.","family":"Smid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.josat.2026.209902_bb0005","doi-asserted-by":"crossref","first-page":"e81","DOI":"10.1097\/AOG.0000000000002235","article-title":"Committee opinion no. 711: Opioid use and opioid use disorder in pregnancy","volume":"130","author":"ACOG","year":"2017","journal-title":"Obstetrics and Gynecology"},{"issue":"1","key":"10.1016\/j.josat.2026.209902_bb0010","doi-asserted-by":"crossref","first-page":"148","DOI":"10.2105\/AJPH.2018.304771","article-title":"Amphetamine- and opioid-affected births: Incidence, outcomes, and costs, United States, 2004-2015","volume":"109","author":"Admon","year":"2019","journal-title":"American Journal of Public Health"},{"key":"10.1016\/j.josat.2026.209902_bb0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2023.109868","article-title":"Duration of medication for opioid use disorder during pregnancy and postpartum by race\/ethnicity: Results from 6 state Medicaid programs","volume":"247","author":"Austin","year":"2023","journal-title":"Drug and Alcohol Dependence"},{"issue":"1","key":"10.1016\/j.josat.2026.209902_bb0025","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.53303","article-title":"Severe maternal morbidity among pregnant people with opioid use disorder enrolled in medicaid","volume":"8","author":"Auty","year":"2025","journal-title":"JAMA Network Open"},{"issue":"12","key":"10.1016\/j.josat.2026.209902_bb0030","doi-asserted-by":"crossref","first-page":"3079","DOI":"10.1111\/add.15959","article-title":"Duration of medication treatment for opioid-use disorder and risk of overdose among Medicaid enrollees in 11 states: A retrospective cohort study","volume":"117","author":"Burns","year":"2022","journal-title":"Addiction"},{"key":"10.1016\/j.josat.2026.209902_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsat.2020.108040","article-title":"Outpatient care for opioid use disorder among the commercially insured: Use of medication and psychosocial treatment","volume":"115","author":"Busch","year":"2020","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"5","key":"10.1016\/j.josat.2026.209902_bb0040","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1097\/MLR.0000000000001838","article-title":"Measurement approaches to estimating methadone continuity in opioid use disorder care","volume":"61","author":"Busch","year":"2023","journal-title":"Medical Care"},{"issue":"1S Suppl 1","key":"10.1016\/j.josat.2026.209902_bb0015","first-page":"1","article-title":"The ASAM\/AAAP Clinical Practice Guideline on the Management of Stimulant Use Disorder","volume":"18","author":"Clinical Guideline Committee (CGC) Members","year":"2024","journal-title":"Journal of Addiction Medicine"},{"key":"10.1016\/j.josat.2026.209902_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2022.109670","article-title":"Outpatient follow-up and use of medications for opioid use disorder after residential treatment among Medicaid enrollees in 10 states","volume":"241","author":"Cole","year":"2022","journal-title":"Drug and Alcohol Dependence"},{"issue":"2","key":"10.1016\/j.josat.2026.209902_bb0050","doi-asserted-by":"crossref","DOI":"10.1097\/ADM.0000000000000193","article-title":"A systematic review on the use of psychosocial interventions in conjunction with medications for the treatment of opioid addiction","volume":"10","author":"Dugosh","year":"2016","journal-title":"Journal of Addiction Medicine"},{"issue":"3","key":"10.1016\/j.josat.2026.209902_bb0055","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.jadohealth.2020.04.026","article-title":"Analysis of pregnancy and birth rates among black and white Medicaid-enrolled teens","volume":"67","author":"Dumas","year":"2020","journal-title":"Journal of Adolescent Health"},{"issue":"7624","key":"10.1016\/j.josat.2026.209902_bb0060","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1136\/bmj.39335.541782.AD","article-title":"Strengthening the reporting of observational studies in epidemiology (STROBE) statement: Guidelines for reporting observational studies","volume":"335","author":"Elm","year":"2007","journal-title":"BMJ (Clinical research ed.)"},{"issue":"4","key":"10.1016\/j.josat.2026.209902_bb0065","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2025.6069","article-title":"Medication for opioid use disorder and treatment retention among pregnant individuals","volume":"8","author":"Ganetsky","year":"2025","journal-title":"JAMA Network Open"},{"issue":"2 Pt 1","key":"10.1016\/j.josat.2026.209902_bb0070","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1097\/AOG.0b013e3181e67094","article-title":"Methamphetamine use during pregnancy: Maternal and neonatal implications","volume":"116","author":"Good","year":"2010","journal-title":"Obstetrics and Gynecology"},{"issue":"7","key":"10.1016\/j.josat.2026.209902_bb0075","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1001\/jamapediatrics.2023.1047","article-title":"Maternal opioid use disorder and the risk of postneonatal infant mortality","volume":"177","author":"Grossarth","year":"2023","journal-title":"JAMA Pediatrics"},{"issue":"3","key":"10.1016\/j.josat.2026.209902_bb0080","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1001\/jamapsychiatry.2023.4523","article-title":"Pregnancy and postpartum drug overdose deaths in the US before and during the COVID-19 pandemic","volume":"81","author":"Han","year":"2024","journal-title":"JAMA Psychiatry"},{"issue":"12","key":"10.1016\/j.josat.2026.209902_bb0085","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1377\/hlthaff.2018.05134","article-title":"How is telemedicine being used in opioid and other substance use disorder treatment?","volume":"37","author":"Huskamp","year":"2018","journal-title":"Health Affairs"},{"issue":"6","key":"10.1016\/j.josat.2026.209902_bb0090","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1097\/ADM.0000000000000792","article-title":"Co-occurring substance use disorders identified among delivery hospitalizations in the United States","volume":"15","author":"Jarlenski","year":"2021","journal-title":"Journal of Addiction Medicine"},{"issue":"3","key":"10.1016\/j.josat.2026.209902_bb0095","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1097\/AOG.0000000000003907","article-title":"Polysubstance use among pregnant women with opioid use disorder in the United States, 2007\u20132016","volume":"136","author":"Jarlenski","year":"2020","journal-title":"Obstetrics & Gynecology"},{"issue":"12","key":"10.1016\/j.josat.2026.209902_bb0100","doi-asserted-by":"crossref","first-page":"3504","DOI":"10.1111\/add.15582","article-title":"Outcomes associated with the use of medications for opioid use disorder during pregnancy","volume":"116","author":"Krans","year":"2021","journal-title":"Addiction"},{"issue":"1","key":"10.1016\/j.josat.2026.209902_bb0105","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1093\/biomet\/73.1.13","article-title":"Longitudinal data analysis using generalized linear models","volume":"73","author":"Liang","year":"1986","journal-title":"Biometrika"},{"issue":"3","key":"10.1016\/j.josat.2026.209902_bb0110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.ss7203a1","article-title":"Medication for opioid use disorder during pregnancy\u2014Maternal and infant network to understand outcomes associated with use of medication for opioid use disorder during pregnancy (MAT-LINK), 2014\u20132021","volume":"72","author":"Miele","year":"2023","journal-title":"MMWR Surveillance Summaries"},{"key":"10.1016\/j.josat.2026.209902_bb0115","series-title":"Psychosocial supports in medication-assisted treatment: Recent evidence and current practice. Appendix B. Findings and Conclusions","author":"Moran","year":"2019"},{"key":"10.1016\/j.josat.2026.209902_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2020.108261","article-title":"Utilization of treatment by Medicaid enrollees with opioid use disorder and co-occurring substance use disorders","volume":"217","author":"O\u2019Brien","year":"2020","journal-title":"Drug and Alcohol Dependence"},{"issue":"11","key":"10.1016\/j.josat.2026.209902_bb0125","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1111\/add.16636","article-title":"Trends and adverse pregnancy and birth outcomes associated with stimulant-related disorder diagnosis","volume":"119","author":"Pippard","year":"2024","journal-title":"Addiction"},{"issue":"4","key":"10.1016\/j.josat.2026.209902_bb0130","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2021-050279","article-title":"Opioid use disorder and perinatal outcomes","volume":"148","author":"Piske","year":"2021","journal-title":"Pediatrics"},{"key":"10.1016\/j.josat.2026.209902_bb0135","series-title":"Opioid use disorder and treatment among pregnant and postpartum medicaid enrollees","author":"Roberts","year":"2023"},{"key":"10.1016\/j.josat.2026.209902_bb0140","series-title":"Substance Abuse and Mental Health Services Administration. A collaborative approach to the treatment of pregnant women with opioid use disorders. HHS Publication No. (SMA) 16-4978","first-page":"2016","author":"SAMHSA","year":"2016"},{"key":"10.1016\/j.josat.2026.209902_bb0145","series-title":"Substance Abuse and Mental Health Services Administration. (2024). Key substance use and mental health indicators in the United States: Results from the 2023 National Survey on Drug Use and Health (HHS Publication No. PEP24-07-021, NSDUH Series H-59)","author":"SAMHSA","year":"2024"},{"issue":"3","key":"10.1016\/j.josat.2026.209902_bb0150","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/s41372-021-01271-8","article-title":"Methamphetamine: Burden, mechanism and impact on pregnancy, the fetus, and newborn","volume":"42","author":"Sankaran","year":"2022","journal-title":"Journal of Perinatology"},{"issue":"1","key":"10.1016\/j.josat.2026.209902_bb0155","doi-asserted-by":"crossref","first-page":"S307","DOI":"10.1016\/j.ajog.2023.11.591","article-title":"566 co-occurring opioid and stimulant use disorders: Is there an incremental impact on adverse pregnancy outcomes?","volume":"230","author":"Schroeder","year":"2024","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"5","key":"10.1016\/j.josat.2026.209902_bb0160","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1055\/s-0032-1304818","article-title":"Prenatal methamphetamine exposure and short-term maternal and infant medical outcomes","volume":"29","author":"Shah","year":"2012","journal-title":"American Journal of Perinatology"},{"key":"10.1016\/j.josat.2026.209902_bb0165","first-page":"1","article-title":"Prevalence of substance use disorder and psychiatric comorbidity burden among pregnant women with opioid use disorder in a large administrative database, 2009\u20132014","author":"Shen","year":"2020","journal-title":"Journal of Psychosomatic Obstetrics and Gynaecology"},{"issue":"6","key":"10.1016\/j.josat.2026.209902_bb0170","doi-asserted-by":"crossref","first-page":"e366","DOI":"10.1097\/ADM.0000000000000987","article-title":"Assessing the impact of prenatal medication for opioid use disorder on discharge home with parents among infants with neonatal opioid withdrawal syndrome","volume":"16","author":"Singleton","year":"2022","journal-title":"Journal of Addiction Medicine"},{"key":"10.1016\/j.josat.2026.209902_bb0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsat.2022.108921","article-title":"Association of polysubstance use disorder with treatment quality among Medicaid beneficiaries with opioid use disorder","volume":"144","author":"Smart","year":"2023","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"1","key":"10.1016\/j.josat.2026.209902_bb0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajogmf.2023.101221","article-title":"Co-occurring opioid and methamphetamine use disorder and severe maternal morbidity and mortality in Utah","volume":"6","author":"Smid","year":"2024","journal-title":"American Journal of Obstetrics & Gynecology MFM"},{"key":"10.1016\/j.josat.2026.209902_bb0185","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1176\/appi.focus.20240023","article-title":"Addressing stigmas that hinder addiction treatment and recovery","volume":"22","author":"Stubbe Dorothy","year":"2024","journal-title":"Focus"},{"key":"10.1016\/j.josat.2026.209902_bb0190","series-title":"U.S. Department of Agriculture, Economic Research Service. 2020 Rural-urban commuting area codes, (July 2025)","author":"USDA","year":"2025"},{"key":"10.1016\/j.josat.2026.209902_bb0195","series-title":"Characteristics of mothers by source of payment for the delivery: United States, 2021","author":"Valenzuela","year":"2023"},{"key":"10.1016\/j.josat.2026.209902_bb0200","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2023.1305508","article-title":"Opioid, methamphetamine, and polysubstance use: Perinatal outcomes for the mother and infant","volume":"11","author":"Wouldes","year":"2023","journal-title":"Frontiers in Pediatrics"},{"issue":"2","key":"10.1016\/j.josat.2026.209902_bb0205","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1097\/ADM.0000000000000101","article-title":"Methamphetamines and pregnancy outcomes","volume":"9","author":"Wright","year":"2015","journal-title":"Journal of Addiction Medicine"},{"issue":"7","key":"10.1016\/j.josat.2026.209902_bb0210","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1038\/s44220-024-00270-w","article-title":"Prescription psychostimulant use, admissions and treatment initiation and retention in pregnant people with opioid use disorder","volume":"2","author":"Xu","year":"2024","journal-title":"Nature Mental Health"},{"issue":"9","key":"10.1016\/j.josat.2026.209902_bb0215","doi-asserted-by":"crossref","DOI":"10.1093\/haschl\/qxae110","article-title":"Insurance acceptance and cash pay rates for psychotherapy in the US","volume":"2","author":"Zhu","year":"2024","journal-title":"Health Affairs Scholar"},{"key":"10.1016\/j.josat.2026.209902_bb0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.josat.2023.209269","article-title":"Co-occurring substance use disorders among patients with opioid use disorder in rural primary care clinics","volume":"158","author":"Zhu","year":"2024","journal-title":"Journal of Substance Use and Addiction Treatment"}],"container-title":["Journal of Substance Use and Addiction Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949875926000226?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949875926000226?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T03:28:05Z","timestamp":1772681285000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2949875926000226"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":44,"alternative-id":["S2949875926000226"],"URL":"https:\/\/doi.org\/10.1016\/j.josat.2026.209902","relation":{},"ISSN":["2949-8759"],"issn-type":[{"value":"2949-8759","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment of opioid use disorder in pregnancy among individuals with and without co-occurring stimulant use disorder: A retrospective cohort study","name":"articletitle","label":"Article Title"},{"value":"Journal of Substance Use and Addiction Treatment","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.josat.2026.209902","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"209902"}}